Discovery of a highly selective and potent kappa opioid receptor agonist from N-cyclopropylmethyl-7α-piperazinyl −6,14-endoethano-tetrahydronorthebaines
Authors:
- 16 May 2026
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 315, 118964
Abstract
No abstract availableKeywords
Funding Information
- Key Technology Research and Development Program of Shandong Province (2021ZD0202900)
- Key Technology Research and Development Program of Shandong Province (2025CXPT178)
- Key Technology Research and Development Program of Shandong Province (2024CXPT029)
- Key Technology Research and Development Program of Shandong Province (2021ZD0203500)
- Natural Science Foundation of Shanghai Municipality (23ZR1474900)
- Natural Science Foundation of Shanghai Municipality (24ZR1413700)
- National Natural Science Foundation of China (82571743)
- Science and Technology Commission of Shanghai Municipality (25DX2800300)
- Taishan Scholar Project of Shandong Province
This publication has 54 references indexed in Scilit:
- Design, synthesis, and biological activity of novel para-substituted phenylamino and phenyl derivatives of northebaine as selective delta opioid receptor agonistsBioorganic & Medicinal Chemistry, 2025
- Difelikefalin: First ApprovalDrugs, 2021
- Dynorphin/kappa-opioid receptor control of dopamine dynamics: Implications for negative affective states and psychiatric disordersBrain Research, 2019
- Structure of the Nanobody-Stabilized Active State of the Kappa Opioid ReceptorCell, 2018
- Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptorCellular Signalling, 2017
- Synthesis of new opioid derivatives with a propellane skeleton and their pharmacologies: Part 5, novel pentacyclic propellane derivatives with a 6-amide side chainBioorganic & Medicinal Chemistry, 2015
- Synthesis and evaluation of κ-opioid receptor agonistic activity and antinociceptive effect of novel morphine analogues, 7α-phenyl-6α,14α-endo-etheno-tetrahydrothebaine with substituted o-, m- and p-amino groupMedicinal Chemistry Research, 2010
- Highly selective and potent μ opioid ligands by unexpected substituent on morphine skeletonBioorganic & Medicinal Chemistry Letters, 2010
- 3D–QSAR studies of orvinol analogs as κ-opioid agonistsJournal of Molecular Modeling, 2006
- Effect of repeated administration of TRK-820, a κ-opioid receptor agonist, on tolerance to its antinociceptive and sedative actionsBrain Research, 2004